the discovery production and marketing of bacteriophage based products to control bacterial pathogens in environmental food processing and medical settings . bacteriophages bacteria eater from the greek phago meaning to eat or to develop at the expense of are the most abundant microorganisms on earth . they are the natural enemies of bacteria . lytic bacteriophages can very effectively kill their targeted specific bacteria without affecting anything else ensuring an unprecedented level of safety for an antimicrobial . in the news intralytix receives usda nifa phase ii sbir grant to develop a phage based application to protect hatchery raised oysters from the bacterial pathogens vibrio tubiashii and vibrio coralliilyticusintralytix inc. announced today that the company has received a sbir phase ii grant from the u.s. department of agriculture usda national institute of food and agriculture nifa intralytix and ferring pharmaceuticals collaborate in novel bacteriophage based ibd drug development project intralytix inc. announced today that it has entered into a collaboration agreement with ferring pharmaceuticals a research driven specialty biopharmaceutical group headquartered in st. prex switzerland . intralytix receives additional regulatory approval for listshield phage based food safety product effective against listeria monocytogenesintralytix inc. announced today that its food safety product listshield has received gras generally recognized as safe recognition from the food and drug administration fda . see more ... food safetyenvironmental sanitationveterinary applicationshuman therapeutics